Published in Joint Bone Spine on January 01, 2000
Pectus excavatum and heritable disorders of the connective tissue. Pediatr Rep (2013) 0.80
Simultaneous extrusion and intrusion of a scleral buckle in a patient with Marfan's syndrome. BMJ Case Rep (2011) 0.75
Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J (2009) 6.64
Diagnosis and management of aortic dissection. Eur Heart J (2001) 5.39
Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet (2007) 2.91
A second locus for Marfan syndrome maps to chromosome 3p24.2-p25. Nat Genet (1994) 2.71
Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer. J Clin Oncol (1998) 2.52
Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology (1999) 2.47
In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome. J Med Genet (2003) 2.26
Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. Arthritis Rheum (2009) 1.88
UMD (Universal mutation database): a generic software to build and analyze locus-specific databases. Hum Mutat (2000) 1.74
Autosomal dominant Marfan-like connective-tissue disorder with aortic dilation and skeletal anomalies not linked to the fibrillin genes. Am J Hum Genet (1993) 1.74
Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci (2000) 1.74
Late onset spondylarthropathy: clinical and biological comparison with early onset patients. Ann Rheum Dis (1997) 1.67
Neuroendocrine primary small cell carcinoma of the breast. Report of a case and review of the literature. Am J Clin Oncol (1995) 1.66
Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial. Br J Anaesth (2011) 1.65
Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry. Ann Rheum Dis (2010) 1.59
Marfan Database (third edition): new mutations and new routines for the software. Nucleic Acids Res (1998) 1.49
Muscle strength and body composition in adult women with Marfan syndrome. Rheumatology (Oxford) (2007) 1.47
Linkage analysis of five fibrillar collagen loci in a large French Marfan syndrome family. J Med Genet (1990) 1.45
Parental origin and germline mosaicism of deletions and duplications of the dystrophin gene: a European study. Hum Genet (1992) 1.44
Possible human chimera detected prenatally after in vitro fertilization: a case report. Prenat Diagn (2003) 1.44
STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis. Arthritis Rheum (2009) 1.43
[Negative D-dimers and peripheral pulmonary embolism]. Arch Mal Coeur Vaiss (2003) 1.42
Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands. J Med Genet (2008) 1.41
Quaternary ammoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctival cells. Invest Ophthalmol Vis Sci (2001) 1.39
[In young children with severe asthma, suspect allergy to peanuts]. Arch Pediatr (1996) 1.38
Tuberculous aortic insufficiency. Report of a case with successful surgical treatment. J Thorac Cardiovasc Surg (1981) 1.36
Genetic heterogeneity of autosomal dominant hypercholesterolemia. Clin Genet (2007) 1.35
A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32. Am J Hum Genet (1999) 1.34
Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry. Ann Rheum Dis (2009) 1.30
[Prevalence and management of heart failure in France: national study among general practitioners of the Sentinelles network]. Rev Med Interne (2005) 1.28
Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol (1992) 1.27
Bovine retina contains three growth factor activities with different affinity to heparin: eye derived growth factor I, II, III. Biochimie (1985) 1.24
Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population. Ann Rheum Dis (2010) 1.22
Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. Invest Ophthalmol Vis Sci (2001) 1.20
NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis. Ann Rheum Dis (2010) 1.19
Flow cytometry in impression cytology specimens. A new method for evaluation of conjunctival inflammation. Invest Ophthalmol Vis Sci (1997) 1.15
The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis. Arthritis Rheum (2008) 1.11
Do patients with low tension glaucoma have particular cardiovascular characteristics? Ophthalmologica (1984) 1.11
Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C. Gut (2003) 1.11
Histone deacetylase inhibitors suppress interleukin-1beta-induced nitric oxide and prostaglandin E2 production in human chondrocytes. Osteoarthritis Cartilage (2008) 1.08
Software and database for the analysis of mutations in the human FBN1 gene. Nucleic Acids Res (1996) 1.08
Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure. Circulation (1999) 1.07
Gender-related factors influencing HIV serostatus disclosure in patients receiving HAART in West Africa. World Health Popul (2008) 1.06
Galectin-3 surface expression on human adult chondrocytes: a potential substrate for collagenase-3. Ann Rheum Dis (2004) 1.05
Specific fixation of bovine brain and retinal acidic and basic fibroblast growth factors to mouse embryonic eye basement membranes. Exp Cell Res (1987) 1.05
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group. Ann Oncol (2003) 1.04
A linkage map of 10 loci flanking the Marfan syndrome locus on 15q: results of an International Consortium study. J Med Genet (1992) 1.04
Predictive factors of total hip replacement due to primary osteoarthritis: a prospective 2 year study of 505 patients. Ann Rheum Dis (2005) 1.03
Mitochondrial activity and glutathione injury in apoptosis induced by unpreserved and preserved beta-blockers on Chang conjunctival cells. Invest Ophthalmol Vis Sci (2001) 1.03
Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey. Eur J Heart Fail (2007) 1.03
Personal and occupational predictors of sciatica in the GAZEL cohort. Occup Med (Lond) (2003) 1.01
Near-maximal fractional oxygen extraction by active skeletal muscle in patients with chronic heart failure. J Appl Physiol (1985) (2000) 1.01
The BMP antagonists follistatin and gremlin in normal and early osteoarthritic cartilage: an immunohistochemical study. Osteoarthritis Cartilage (2008) 1.01
Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-alpha antagonist therapy: safe re-initiation of TNF-alpha blockers after appropriate anti-tuberculous treatment. Clin Microbiol Infect (2007) 0.99
Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity. Ann Rheum Dis (2008) 0.99
Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis. Arthritis Rheum (2011) 0.98
Fibulin-2: genetic mapping and exclusion as a candidate gene in Marfan syndrome type 2. Eur J Hum Genet (1996) 0.98
Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin. Rheumatology (Oxford) (2008) 0.98
The new Ghent criteria for Marfan syndrome: what do they change? Clin Genet (2011) 0.98
BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4. Arthritis Rheum (2009) 0.98
A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: report of the Clinical Screening Group of the EORTC. Ann Oncol (1996) 0.97
Bone mineral density in sixty adult patients with Marfan syndrome. Osteoporos Int (1999) 0.97
Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotype. Arthritis Rheum (2011) 0.96
Lack of association between the protein tyrosine phosphatase non-receptor 22 (PTPN22)*620W allele and systemic sclerosis in the French Caucasian population. Ann Rheum Dis (2006) 0.96
No evidence of somatic FGFR3 mutation in various types of carcinoma. Oncogene (2001) 0.96
LDLR Database (second edition): new additions to the database and the software, and results of the first molecular analysis. Nucleic Acids Res (1998) 0.96
French myotonic dystrophy families show expansion of a CTG repeat in complete linkage disequilibrium with an intragenic 1 kb insertion. J Med Genet (1994) 0.95
Low incidence of stroke in ambulatory patients with heart failure: a prospective study. Am Heart J (1993) 0.95
Association between an endoglin gene polymorphism and systemic sclerosis-related pulmonary arterial hypertension. Rheumatology (Oxford) (2006) 0.95
Evidence and characterization of the receptor to eye-derived growth factor I, the retinal form of basic fibroblast growth factor, on bovine epithelial lens cells. Proc Natl Acad Sci U S A (1986) 0.95
Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population. Arthritis Rheum (2010) 0.94
Left main coronary artery compression during primary pulmonary hypertension. Chest (1997) 0.93
Inflammatory breast cancer. Determination of prognostic factors by univariate and multivariate analysis. Cancer (1987) 0.93
Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions. Arthritis Rheum (2008) 0.93
[Marfan syndrome: diagnostic criteria and molecular biology contribution]. Arch Pediatr (2008) 0.93
Software and database for the analysis of mutations in the human LDL receptor gene. Nucleic Acids Res (1997) 0.92
Clinical and mutation-type analysis from an international series of 198 probands with a pathogenic FBN1 exons 24-32 mutation. Eur J Hum Genet (2008) 0.92
Spring-mass model characteristics during sprint running: correlation with performance and fatigue-induced changes. Int J Sports Med (2006) 0.92
Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards. Eur J Clin Microbiol Infect Dis (2011) 0.91
Serum hyaluronan (hyaluronic acid) in breast cancer patients. Int J Cancer (1990) 0.90
[Marfan syndrome]. Arch Mal Coeur Vaiss (2003) 0.90
Systematic molecular and cytogenetic screening of 100 patients with marfanoid syndromes and intellectual disability. Clin Genet (2013) 0.90
Demonstration of the recurrence of Marfan-like skeletal and cardiovascular manifestations due to germline mosaicism for an FBN1 mutation. Am J Hum Genet (1999) 0.89
Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity. J Clin Oncol (1995) 0.89
Comparison of treadmill and bicycle exercise in patients with chronic heart failure. Chest (1994) 0.89
A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy. J Clin Oncol (1990) 0.89
A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapy. Eur J Cancer (1996) 0.88
Identification of opticin, a member of the small leucine-rich repeat proteoglycan family, in human articular tissues: a novel target for MMP-13 in osteoarthritis. Osteoarthritis Cartilage (2008) 0.88
Marfan Database (second edition): software and database for the analysis of mutations in the human FBN1 gene. Nucleic Acids Res (1997) 0.88